Update on Metastatic Uveal Melanoma: Progress and Challenges
- PMID: 27000042
- DOI: 10.1007/s40259-016-0167-4
Update on Metastatic Uveal Melanoma: Progress and Challenges
Abstract
Uveal melanoma is a rare and biologically distinct type of melanoma arising from melanocytes of the uveal tract; it is associated with a poor prognosis due to the lack of effective systemic treatments. Recent advances in the pathogenesis of uveal melanoma offer an unprecedented opportunity for investigation of new compounds. The purpose of this paper was to analyse the existing evidence about the molecular pathology and immunobiology of advanced uveal melanoma and their implications for systemic targeted therapies and immunotherapy, as well as to discuss future treatment strategies based on data provided by clinical and translational research studies.
Similar articles
-
Evolving systemic targeted therapy strategies in uveal melanoma and implications for ophthalmic management: a review.Clin Exp Ophthalmol. 2016 Aug;44(6):509-19. doi: 10.1111/ceo.12688. Epub 2016 Feb 11. Clin Exp Ophthalmol. 2016. PMID: 26601795 Review.
-
Uveal melanoma.Cancer Treat Rev. 2012 Aug;38(5):549-53. doi: 10.1016/j.ctrv.2012.01.002. Epub 2012 Jan 24. Cancer Treat Rev. 2012. PMID: 22270078 Review.
-
Recent breakthroughs in metastatic uveal melanoma: a cause for optimism?Future Oncol. 2018 Jun;14(14):1335-1338. doi: 10.2217/fon-2018-0116. Epub 2018 May 9. Future Oncol. 2018. PMID: 29741103 No abstract available.
-
Immunotherapy for Uveal Melanoma.Int Ophthalmol Clin. 2017 Winter;57(1):29-39. doi: 10.1097/IIO.0000000000000148. Int Ophthalmol Clin. 2017. PMID: 27898611 Review. No abstract available.
-
Pathology and genetics of uveal melanoma.Pathology. 2013 Jan;45(1):18-27. doi: 10.1097/PAT.0b013e32835c6505. Pathology. 2013. PMID: 23222249 Review.
Cited by
-
Immunogenic profiling of metastatic uveal melanoma discerns a potential signature related to prognosis.J Cancer Res Clin Oncol. 2024 Jan 21;150(1):23. doi: 10.1007/s00432-023-05542-z. J Cancer Res Clin Oncol. 2024. PMID: 38246894 Free PMC article.
-
SUMOylation regulates Rb hyperphosphorylation and inactivation in uveal melanoma.Cancer Sci. 2022 Feb;113(2):622-633. doi: 10.1111/cas.15223. Epub 2021 Dec 20. Cancer Sci. 2022. PMID: 34839558 Free PMC article.
-
Abnormally expressed JunB transactivated by IL-6/STAT3 signaling promotes uveal melanoma aggressiveness via epithelial-mesenchymal transition.Biosci Rep. 2018 Jul 2;38(4):BSR20180532. doi: 10.1042/BSR20180532. Print 2018 Aug 31. Biosci Rep. 2018. Retraction in: Biosci Rep. 2023 May 31;43(5):BSR-2018-0532_RET. doi: 10.1042/BSR-2018-0532_RET PMID: 29899166 Free PMC article. Retracted.
-
Identification of a prognostic six-immune-gene signature and a nomogram model for uveal melanoma.BMC Ophthalmol. 2023 Jan 3;23(1):2. doi: 10.1186/s12886-022-02723-1. BMC Ophthalmol. 2023. PMID: 36597071 Free PMC article.
-
ZEB1 Regulates Multiple Oncogenic Components Involved in Uveal Melanoma Progression.Sci Rep. 2017 Mar 3;7(1):45. doi: 10.1038/s41598-017-00079-x. Sci Rep. 2017. PMID: 28246385 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical